SYNSPIRA
Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases. Inspired by patients and frustrated by the limitations of conventional treatments, Synspira is advancing two novel products (SNSP113 and SNSP003) in order to provide better clinical outcomes and reduce treatment burden in Progressive Pulmonary Disease and Malabsorption Syndromes.
SYNSPIRA
Industry:
Biotechnology Information Technology Therapeutics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.synspira.com
Total Employee:
11+
Status:
Active
Contact:
(781) 235-3060
Email Addresses:
[email protected]
Total Funding:
25.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Miller Family Trust
Miller Family Trust investment in Venture Round - Synspira
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Venture Round - Synspira
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Synspira
Official Site Inspections
http://www.synspira.com Semrush global rank: 3.72 M Semrush visits lastest month: 3.68 K
- Host name: afirmate.com
- IP address: 173.236.189.35
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
